Finding Uninjured Consumers In Drug Antitrust Class Actions
In an amicus brief filed in March opposing an appeal from end payers seeking to certify a class of end purchasers of the cholesterol drug Niaspan in In re: Niaspan Antitrust...To view the full article, register now.
Already a subscriber? Click here to view full article